Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Bliss Gvs Pharma Limited ( (IN:BLISSGVS) ) just unveiled an update.
Bliss GVS Pharma Limited has expanded its African presence through its Singapore-based wholly owned subsidiary, Bliss GVS International PTE Ltd, which has incorporated a new step-down wholly owned subsidiary, THERALIFE PHARMA RDC PRIVATE LIMITED, in Kinshasa–Gombe, Democratic Republic of the Congo. The new entity, established with a modest initial share capital of USD 1,000, signals the company’s continued strategic push into emerging healthcare markets, potentially strengthening its distribution, local market access, and positioning within the regional pharmaceutical landscape, though detailed operational plans and financial implications have not yet been disclosed.
More about Bliss Gvs Pharma Limited
Bliss GVS Pharma Limited operates in the pharmaceutical and healthcare sector, offering a range of pharma products with a growing international footprint supported by wholly owned subsidiaries in key overseas markets.
Average Trading Volume: 425,743
Technical Sentiment Signal: Buy
Current Market Cap: 17.13B INR
See more insights into BLISSGVS stock on TipRanks’ Stock Analysis page.